Subcutaneous Keytruda Wins Approval, Revolutionizing Cancer Treatment Access

Drug Approvals /

Keytruda is a type of cancer immunotherapy that helps the body’s immune system fight cancer. It’s used to treat many different cancers, including:Melanoma (a type of skin cancer) • Non-small cell lung cancer • Head and neck cancer • Bladder and urinary tract cancer • Cervical cancer • Certain types of breast cancer • Colorectal cancer • Endometrial cancer • Stomach cancer • Hodgkin […]

Subcutaneous Keytruda Wins Approval, Revolutionizing Cancer Treatment Access Read More »

Researchers Uncover Hidden DNA Drivers of Deadly Brain Cancer

Research Advances /

An international research team has discovered that extrachromosomal DNA (ecDNA) rings, which float outside chromosomes, can drive the early development of glioblastoma, the most aggressive adult brain cancer. The study, published in Cancer Discovery, shows that ecDNA containing cancer-driving genes, especially EGFR, often appears before tumors fully form, fueling rapid growth, adaptability, and treatment resistance.

Researchers Uncover Hidden DNA Drivers of Deadly Brain Cancer Read More »

Nutrition Innovations in Cancer Care

News /

Nutrition is shifting from supportive care to a central role in cancer therapy. Advances in genomics, metabolomics, and microbiome science now enable personalized diets tailored to each patient’s biology. These strategies aim to improve treatment response, reduce side effects, and support overall health. Researchers are testing microbiome-focused diets with prebiotics and probiotics, as well as

Nutrition Innovations in Cancer Care Read More »

Precision Medicine Revolution: Targeted Therapies and Immunotherapy Transform Brain Cancer Treatment

Precision Medicine /

ITargeted therapies are transforming brain tumor treatment by focusing on specific genetic mutations rather than broadly attacking all dividing cells. This improves precision and reduces side effects. A key example is Vorasidenib, approved for gliomas with IDH1 or IDH2 mutations, which can delay tumor progression. Researchers are also developing agents like MT-125 that disrupt cancer

Precision Medicine Revolution: Targeted Therapies and Immunotherapy Transform Brain Cancer Treatment Read More »

From Liquid Biopsies to Surgical Precision: How AI is Transforming Brain Cancer Diagnosis

Technology Innovation /

Traditional liquid biopsies for brain cancer are limited by the blood-brain barrier, but new AI-driven methods are improving detection. Researchers at Johns Hopkins University developed a technique that analyzes DNA fragments from tumors and immune cells in the blood, achieving about 75% detection in early studies. Another system, crossNN, examines epigenetic signatures and can classify

From Liquid Biopsies to Surgical Precision: How AI is Transforming Brain Cancer Diagnosis Read More »

FDA Approves INLEXZO™: First Extended-Release Bladder Cancer Treatment System

Drug Approvals /

On September 9, 2025, the U.S. Food and Drug Administration approved INLEXZO™ (gemcitabine intravesical system), developed by Janssen Biotech. It is the first device that continuously releases chemotherapy inside the bladder for cancer treatment. Instead of placing liquid chemotherapy in the bladder for one to two hours per visit, this small flexible tube stays in

FDA Approves INLEXZO™: First Extended-Release Bladder Cancer Treatment System Read More »

Precision Medicine Revolution: Stage-Specific Innovations Transform Ovarian Cancer Treatment

Precision Medicine /

Ovarian cancer treatment is becoming more personalized and stage-specific, guided by tumor genetics. In early stages (I–II), minimally invasive and robotic surgeries reduce recovery time and pain. Fertility-sparing surgery allows some younger patients to preserve reproductive potential. Genomic profiling is also helping determine which patients truly need chemotherapy, avoiding unnecessary side effects. In advanced stages

Precision Medicine Revolution: Stage-Specific Innovations Transform Ovarian Cancer Treatment Read More »

Revolutionary Technologies Transform Early Ovarian Cancer Detection

Diagnostics /

New technologies are transforming early ovarian cancer detection, aiming to identify this “silent killer” at more treatable stages. AI-powered tools like Ovatools combine biomarkers such as CA125 with patient data to generate personalized risk scores, improving early diagnosis. Machine learning is also being used to analyze metabolic patterns in blood, detecting subtle cancer signals with

Revolutionary Technologies Transform Early Ovarian Cancer Detection Read More »

Pancreatic Cancer Treatment Revolution: Breakthrough Therapies Target the “Untreatable”

News, Treatment /

n September 9, 2025, the FDA approved INLEXZO™ (gemcitabine intravesical system) by Janssen Biotech. It is the first device that releases chemotherapy directly inside the bladder over time. Unlike traditional treatments where liquid chemo stays in the bladder for 1–2 hours, INLEXZO™ is a small tube that stays in the bladder and delivers the drug

Pancreatic Cancer Treatment Revolution: Breakthrough Therapies Target the “Untreatable” Read More »

Breaking Through Pancreatic Cancer’s Silent Threat: Revolutionary Early Detection Methods

Diagnostics /

New technologies are advancing early pancreatic cancer detection using highly sensitive blood tests and AI. Magnetic nanosensors can detect tumor-released proteases from just a small blood sample in under an hour at extremely low cost. When combined with CA 19-9, early-stage detection accuracy reaches about 85%. AI-powered DNA fragment analysis also shows strong results, with

Breaking Through Pancreatic Cancer’s Silent Threat: Revolutionary Early Detection Methods Read More »